Q2
ELV — Q2 2026 Financial Report Analysis
Elevance Health Q2 2026: profit fell 16.1% to $1.46B (EPS $6.71) as Medicaid and Medicare costs pushed the benefit expense ratio to 89.7%, yet a beat and higher investment income let it raise full-year adjusted EPS guidance to at least $27.00.